BOUNDLESS BIO INC (BOLD) Stock Income Statement
NASDAQ:BOLD - Nasdaq - US10170A1007 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 73.27M | 54.80M | 46.47M | 25.30M | |||
| Research and Development | 55.27M | 42.64M | 37.16M | 19.28M | |||
| Selling, General, and Administrative Expenses | 18.00M | 12.16M | 9.31M | 6.02M | |||
| Operating Income | -73.27M | -54.80M | -46.47M | -25.30M | |||
| Interest Income/Expense | 7.89M | 5.28M | 668.00K | 96.00K | |||
| Other Income/Expense | 12.00K | 80.00K | -100.00K | -5.00K | |||
| Income Before Taxes | -65.36M | -49.43M | -45.90M | -25.21M | |||
| Net Income | -65.36M | -49.43M | -45.90M | -25.21M | |||
| EBITDA | -72.18M | -53.84M | -45.53M | -24.62M | |||
| Per Share Data | |||||||
| EPS Diluted Total Ops | -3.85 | -2.22 | -2.06 | -1.13 | |||
| Non GAAP EPS | -14.52 | N/A | N/A | N/A | |||
| Statistics | |||||||
All data in USD